Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioHarvest Sciences ( (BHST) ) has issued an announcement.
BioHarvest Sciences has announced that its VINIA brand is now the top-selling resveratrol polyphenol nutraceutical in the U.S., less than five years after entering the market. The product’s position is underpinned by clinically demonstrated benefits in increasing arterial dilation and improving blood flow, as well as a subscription-driven model that has built a strong e-commerce presence.
The company reported more than $30 million in VINIA U.S. revenue for 2025 and about $85 million in cumulative global sales, supported by over 85,000 active users. Management and medical advisors say VINIA’s performance and its plant-cell delivery system validate BioHarvest’s Botanical Synthesis technology, which concentrates piceid resveratrol up to 100 times natural grape levels and is expected to serve as a platform for additional synergistic nutraceutical products.
The most recent analyst rating on (BHST) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
Spark’s Take on BHST Stock
According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.
The score is held down primarily by weak financial performance (ongoing net losses, negative operating/free cash flow, and elevated leverage) and bearish technicals (below key moving averages with negative MACD). The latest earnings call adds support via strong revenue growth, improving gross margins, and guidance pointing toward adjusted EBITDA breakeven, but valuation remains constrained by unprofitability and no dividend.
To see Spark’s full report on BHST stock, click here.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a biotechnology company that develops plant-based nutraceuticals using its proprietary Botanical Synthesis platform. Its flagship product, VINIA, is a red grape-derived resveratrol polyphenol supplement focused on cardiovascular and vascular health, sold primarily via a direct-to-consumer e-commerce model in the U.S. and Israel.
Average Trading Volume: 27,688
Technical Sentiment Signal: Buy
Current Market Cap: $98.77M
Find detailed analytics on BHST stock on TipRanks’ Stock Analysis page.